| Previous close | 9.30 |
| Open | 9.30 |
| Bid | 6.60 |
| Ask | 7.20 |
| Strike | 50.00 |
| Expiry date | 2024-11-15 |
| Day's range | 9.30 - 9.30 |
| Contract range | N/A |
| Volume | |
| Open interest | 32 |
GlobeNewswireQIAGEN expands QIAcuity digital PCR offering with over new 100 assays via GeneGlobe platform
QIAGEN adds over 100 new validated QIAcuity digital PCR assays for cancer research, inherited genetic disorders, infectious disease surveillance, and other applications // QIAcuity digital PCR enables accurate and sensitive detection of low-abundance pathogens, copy number alterations and identification of rare mutations // Portfolio expansion and partnerships support increased adoption of QIAcuity across multiple application areasVenlo, the Netherlands, Sept. 18, 2024 (GLOBE NEWSWIRE) -- QIAGEN
ZacksQGEN Stock Likely to Gain From Innovation Amid Competition
To support internal growth, QIAGEN invests heavily in research and development for the menu expansion of its key platforms.
- Zacks
Can QGEN Stock Gain From the Expanded Bio-Manguinhos/Fiocruz Alliance?
QIAGEN and Bio-Manguinhos/Fiocruz team up to enhance malaria and dengue detection in Brazil's national screening programs.
© 2024 Yahoo. All rights reserved.